Brief: ValiRx Announces Evaluation And Material Transfer Agreement With Omios Biologics
03/06/2025 07:30
June 3 (Reuters) - ValiRx PLC VALX.L: VALIRX PLC - NEW EVALUATION AND MATERIAL TRANSFER AGREEMENT VALIRX PLC - AGREEMENT EXPECTED TO TAKE UP TO 12 MONTHS FOR A NOMINAL UPFRONT PAYMENT VALIRX PLC - OMIOS HAS OPTION TO ENTER ONCOLYTIC PEPTIDE LICENSE AGREEMENT ON CONCLUSION OF EVALUATION Source text: ID:nRSC1164La Further company coverage: VALX.L ((( Reuters.Briefs@thomsonreuters.com );))